I. Anghelescu

Till F. M. Andlauer, M. Rietschel, M. Nöthen, 2018, American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics.

Interplay between the genetics of personality traits, severe psychiatric disorders and COVID-19 host genetics in the susceptibility to SARS-CoV-2 infection

Till F. M. Andlauer, O. Andreassen, M. Rietschel, 2021, BJPsych Open.

Diabetes und Depression

I. Heuser, A. Merkl, F. Regen, 2005 .

The role of environmental stress and DNA methylation in the longitudinal course of bipolar disorder

Till F. M. Andlauer, M. Rietschel, M. Nöthen, 2019, International Journal of Bipolar Disorders.

Stress management and the role of Rhodiola rosea: a review

E. Seifritz, S. Kasper, I. Anghelescu, 2018, International journal of psychiatry in clinical practice.

Polygenic risk scores across the extended psychosis spectrum

Till F. M. Andlauer, M. Rietschel, M. Nöthen, 2021, Translational Psychiatry.

Serotonergic polymorphisms in patients suffering from alcoholism, anxiety disorders and narcolepsy

N. Dahmen, A. Szegedi, C. Hiemke, 2001, Progress in Neuro-Psychopharmacology and Biological Psychiatry.

HDAC1 links early life stress to schizophrenia-like phenotypes

Alexander E. Dityatev, T. Schulze, P. Falkai, 2017, Proceedings of the National Academy of Sciences.

An Investigation of Psychosis Subgroups With Prognostic Validation and Exploration of Genetic Underpinnings: The PsyCourse Study.

Till F. M. Andlauer, M. Rietschel, M. Nöthen, 2020, JAMA psychiatry.

Confirmation of association of the GABRA2 gene with alcohol dependence by subtype-specific analysis

N. Dahmen, A. Szegedi, T. Sander, 2006, Psychiatric genetics.

Valproic Acid and hypersensitivity syndrome.

S. Roepke, R. Treudler, C. Orfanos, 2004, The American journal of psychiatry.

Haplotypes of dopamine and serotonin transporter genes are associated with antisocial personality disorder in alcoholics

G. Winterer, J. Gallinat, J. Reese, 2010, Psychiatric genetics.

Successful switch to aripiprazole after induction of hyperprolactinemia by ziprasidone: a case report.

I. Anghelescu, J. Wolf, 2004, Journal of Clinical Psychiatry.

Distigmine bromide induced acute psychotic disorder in a patient with multiple sclerosis

Matthias J. Müller, A. Szegedi, H. Himmerich, 2003, European Psychiatry.

Mirtazapine Review of its Use in Major Depression and Other

S. Kasper, H. Uchida, J. Ishigooka, 2009 .

Childhood maltreatment and adult proinflammatory status in patients with major depression.

I. Heuser, M. Bajbouj, A. Quante, 2013, Psychiatria Danubina.

The HTR1B 861G>C receptor polymorphism among patients suffering from alcoholism, major depression, anxiety disorders and narcolepsy

N. Dahmen, A. Szegedi, C. Hiemke, 2000, Psychiatry Research.

P.3.c.046 Efficacy and safety of JNJ 37822681, a fast dissociating D2 receptor antagonist, in the treatment of schizophrenia

L. Janssens, E. Mannaert, J. Kent, 2010, European Neuropsychopharmacology.

Inflammatory biomarkers in 70 depressed inpatients with and without the metabolic syndrome.

R. Schwarzer, I. Heuser, A. Quante, 2010, The Journal of clinical psychiatry.

Medication Adherence in a Cross-Diagnostic Sample of Patients From the Affective-to-Psychotic Spectrum: Results From the PsyCourse Study

T. Schulze, G. Juckel, P. Falkai, 2022, Frontiers in Psychiatry.

Association of VMAT2 gene polymorphisms with alcohol dependence

N. Dahmen, A. Szegedi, P. Zill, 2013, Journal of Neural Transmission.

Early improvement under mirtazapine and paroxetine predicts later stable response and remission with high sensitivity in patients with major depression.

Matthias J. Müller, A. Szegedi, O. Benkert, 2003, The Journal of clinical psychiatry.

Psychopharmacological Treatment Status in Outpatients with Bipolar Disorder: A Clinical Survey in Germany

A. Quante, F. Regen, I. Anghelescu, 2010, Psychiatry investigation.

Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo‐controlled pilot study

C. Born, A. Quante, A. Luborzewski, 2010, Human psychopharmacology.

Clonidine Improves Hyperarousal in Borderline Personality Disorder With or Without Comorbid Posttraumatic Stress Disorder: A Randomized, Double-Blind, Placebo-Controlled Trial

I. Heuser, A. Merkl, H. Danker-Hopfe, 2009, Journal of clinical psychopharmacology.

Pathways linking early life stress, metabolic syndrome, and the inflammatory marker fibrinogen in depressed inpatients.

I. Heuser, A. Quante, W. Kössler, 2012, Psychiatria Danubina.

[Psychopharmacologic treatment of personality disorders].

A. Merkl, A. Quante, C. Lammers, 2008, Fortschritte der Neurologie-Psychiatrie.

Subthalamic nucleus stimulation in severe obsessive-compulsive disorder.

M. Dettling, I. Anghelescu, 2009, The New England journal of medicine.

Lithium versus lamotrigine augmentation in treatment resistant unipolar depression: a randomized, open-label study

I. Anghelescu, F. Schindler, 2007, International clinical psychopharmacology.

Clozapine in medication- and electroconvulsive therapy-resistant, depressed inpatients: a case series.

M. Bajbouj, A. Quante, I. Anghelescu, 2007, Journal of clinical psychopharmacology.

Declarative and procedural memory consolidation during sleep in patients with borderline personality disorder.

I. Heuser, H. Danker-Hopfe, F. Regen, 2008, Journal of psychiatric research.

Lamotrigine compared to placebo and other agents with antidepressant activity in patients with unipolar and bipolar depression: a comprehensive meta-analysis of efficacy and safety outcomes in short-term trials

C. Normann, C. Correll, N. Veronese, 2016, CNS Spectrums.

Reply to: Continuation Antidepressant Strategies After Electroconvulsive Therapy: Ultrabrief Pulse Versus Cognitive-Behavioral Therapy

I. Heuser, N. Kathmann, A. Merkl, 2015, Biological Psychiatry.

Efficacy of orally administered Silexan in patients with anxiety-related restlessness and disturbed sleep – A randomized, placebo-controlled trial

S. Kasper, A. Dienel, I. Anghelescu, 2015, European Neuropsychopharmacology.

The influence of daytime napping versus controlled activity on the subjective well-being of patients with major depression

I. Heuser, M. Bajbouj, F. Regen, 2012, Psychiatry Research.

Low novelty seeking and high self directedness scores in alcohol-dependent patients without comorbid psychiatric disorders homozygous for the A10 allele of the dopamine transporter gene

N. Dahmen, A. Szegedi, A. Quante, 2010 .

Low novelty seeking and high self directedness scores in alcohol-dependent patients without comorbid psychiatric disorders homozygous for the A10 allele of the dopamine transporter gene.

N. Dahmen, A. Szegedi, A. Quante, 2010, The world journal of biological psychiatry : the official journal of the World Federation of Societies of Biological Psychiatry.

Early Improvement As a Predictor of Later Response to Antipsychotics in Schizophrenia: A Diagnostic Test Review.

D. Rujescu, I. Giegling, H. Möller, 2015, The American journal of psychiatry.

Variant GADL1 and response to lithium in bipolar I disorder.

M. Dettling, I. Anghelescu, 2014, The New England journal of medicine.

Preliminary Evidence of Improvement of Depressive Symptoms but not Impulsivity in Cluster B Personality Disorder Patients Treated with Quetiapine: an Open Label Trial

I. Heuser, A. Merkl, S. Roepke, 2008, Pharmacopsychiatry.

The influence of religious activity and polygenic schizophrenia risk on religious delusions in schizophrenia

Till F. M. Andlauer, M. Rietschel, M. Nöthen, 2019, Schizophrenia Research.

Drug-Induced Liver Injury (DILI) in Patients with Depression Treated with Antidepressants: A Retrospective Multicenter Study

P. Zwanzger, J. Kuhn, T. Messer, 2020, Pharmacopsychiatry.

The “DGPPN-Cohort”: a national collaboration initiative by the German Association for Psychiatry and Psychotherapy (DGPPN) for establishing a large-scale cohort of psychiatric patients

Matthias J. Müller, D. Rujescu, M. Rietschel, 2013, European Archives of Psychiatry and Clinical Neuroscience.

Tapering of SSRI treatment to mitigate withdrawal symptoms.

G. Kronenberg, D. Desai, I. Anghelescu, 2019, The lancet. Psychiatry.

Issues and perspectives in designing clinical trials for negative symptoms in schizophrenia

Michael F. Green, Philip D. Harvey, A. Malhotra, 2013, Schizophrenia Research.

Association between mitochondria-related genes and cognitive performance in the PsyCourse Study.

M. Rietschel, T. Schulze, G. Juckel, 2023, Journal of affective disorders.

Investigating polygenic burden in age at disease onset in bipolar disorder: Findings from an international multicentric study

Janice M. Fullerton, S. Cichon, M. Rietschel, 2018, Bipolar disorders.

Association of Polygenic Score and the involvement of Cholinergic and Glutamatergic Pathways with Lithium Treatment Response in Patients with Bipolar Disorder

Marius K. Koch, Till F. M. Andlauer, S. Cichon, 2023, Research square.

Interplay between the Genetics of Personality Traits, severe Psychiatric Disorders, and COVID-19 Host Genetics in the Susceptibility to SARS-CoV-2 Infection - ADDENDUM

O. Andreassen, M. Rietschel, M. Nöthen, 2021, BJPsych Open.

Quetiapine as combination treatment with citalopram in unipolar depression with prominent somatic symptoms: a randomised, double-blind, placebo-controlled pilot study.

E. Severus, A. Quante, A. Luborzewski, 2013, Psychiatria Danubina.

Association of polygenic score and the involvement of cholinergic and glutamatergic pathways with lithium treatment response in patients with bipolar disorder.

Marius K. Koch, S. Cichon, M. Rietschel, 2023, Molecular psychiatry.

A genome-wide association study of the longitudinal course of executive functions

T. Schulze, G. Juckel, P. Falkai, 2021, Translational Psychiatry.

Association of the dopamine D2 receptor gene with alcohol dependence: haplotypes and subgroups of alcoholics as key factors for understanding receptor function

G. Winterer, J. Gallinat, J. Reese, 2009, Pharmacogenetics and genomics.

A Novel Study Design to Systematically Explore the Impact of Trial Methodology on Psychopharmacological Treatment Outcome in Patients with Depression

M. Ostacher, M. Bauer, E. Severus, 2018, Pharmacopsychiatry.

Escitalopram, problem-solving therapy, and poststroke depression.

C. Opgen-Rhein, M. Dettling, I. Anghelescu, 2008, JAMA.

Successful smoking cessation and improvement of negative symptoms with varenicline in a stable schizophrenia patient.

I. Anghelescu, 2009, The Journal of neuropsychiatry and clinical neurosciences.

Intracellular ADP activates ATP-sensitive K+ channels in vascular smooth muscle cells of the guinea pig portal vein

V. Kreye, I. Anghelescu, D. Pfründer, 1993, Pflügers Archiv.

Comparison of Hypericum Extract WS® 5570 and Paroxetine in Ongoing Treatment after Recovery from an Episode of Moderate to Severe Depression: Results from a Randomized Multicenter Study

A. Szegedi, R. Kohnen, M. Kieser, 2006, Pharmacopsychiatry.

Superior efficacy of St John's wort extract WS®5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]

A. Szegedi, A. Dienel, M. Kieser, 2006 .

Long-term outcome of vagus nerve stimulation in rapid-cycling bipolar disorder.

I. Heuser, M. Bajbouj, H. Danker-Hopfe, 2006, The Journal of clinical psychiatry.

Medication adherence and cognitive performance in schizophrenia-spectrum and bipolar disorder: results from the PsyCourse Study

T. Schulze, G. Juckel, A. Fallgatter, 2023, Translational Psychiatry.

Improvement in refractory obsessive compulsive disorder with dronabinol.

F. Regen, I. Anghelescu, F. Schindler, 2008, American Journal of Psychiatry.

[Therapeutic effects of venlafaxine extended release for patients with depressive and anxiety disorders in the German outpatient setting - results of 2 observational studies including 8500 patients].

H. Volz, I. Anghelescu, W. Dierkes, 2009, Fortschritte der Neurologie Psychiatrie.

The Effects of Donepezil on Postlearning Sleep EEG of Healthy Older Adults

N. Kathmann, H. Danker-Hopfe, H. Dorn, 2009, Pharmacopsychiatry.

Superior efficacy of St John's wort extract WS® 5570 compared to placebo in patients with major depression: a randomized, double-blind, placebo-controlled, multi-center trial [ISRCTN77277298]

S. Kasper, A. Szegedi, A. Dienel, 2006, BMC medicine.

Ultrahigh frequency repetitive transcranial magnetic stimulation in unipolar depression.

I. Heuser, A. Merkl, M. Bajbouj, 2008, Journal of clinical psychopharmacology.

Cognitive-Behavioral Therapy as Continuation Treatment to Sustain Response After Electroconvulsive Therapy in Depression: A Randomized Controlled Trial

I. Heuser, N. Kathmann, A. Merkl, 2014, Biological Psychiatry.

Omega-3 fatty acids for CHD with depression.

I. Anghelescu, 2010, JAMA.

Venlafaxine in a patient with idiopathic leukopenia and mirtazapine-induced severe neutropenia.

N. Dahmen, I. Anghelescu, C. Klawe, 2002, The Journal of clinical psychiatry.

The TPH intron 7 A218C polymorphism and TCI dimension scores in alcohol-dependent patients: hints to nonspecific psychopathology.

N. Dahmen, A. Szegedi, H. Himmerich, 2005, Addictive behaviors.

Aripiprazole as adjunct to a mood stabilizer and citalopram in bipolar depression: a randomized placebo‐controlled pilot study

C. Born, A. Quante, A. Luborzewski, 2010, Human psychopharmacology.

Housing for Homeless Adults With Mental Illness.

M. Dettling, I. Anghelescu, 2015, JAMA.

Fluoxetine for treatment of anorexia nervosa.

A. Quante, C. Opgen-Rhein, M. Dettling, 2006, JAMA.

I. Heuser, H. Danker-Hopfe, F. Regen, 2008, Depression and anxiety.

Psychotropics and risk of violent crime

M. Dettling, I. Anghelescu, 2014, The Lancet.

The influence of daytime napping versus controlled activity on the subjective well-being of patients with major depression

I. Heuser, M. Bajbouj, F. Regen, 2012, Psychiatry Research.